(HealthDay)—Liraglutide treatment for weight management is not associated with increased risk of cardiovascular events, according to a study published online Sept. 26 in Diabetes, Obesity and Metabolism.
Oct 13, 2017
0
1
Researchers from Houston Methodist Hospital and five partner institutions used data from a major stroke clinical study to show that medical centers with more experience and expertise in aggressive medical management had a ...
Dec 14, 2015
0
5
(HealthDay)—Salpingectomy alone may be a risk management option for women at hereditary risk of ovarian cancer, according to a review published in the May issue of Cancer Prevention Research.
Apr 22, 2015
0
3
Small businesses are prepared to adopt workplace wellness programs and, based on the kinds of health risks facing employees, are a good target for such health interventions according to new research published in this month's ...
Jan 22, 2015
0
4
Health is high on the agenda in many countries with efforts to get more people exercising in order to reduce the problems associated with obesity, such as diabetes, cardiovascular disease and cancer.
Dec 2, 2014
0
0
Having a pharmacist call patients at home to go over their medications can identify many medication-based problems. However, a new study in Health Services Research found that pharmacist-patient telephone consultations only ...
Apr 11, 2014
0
0
(HealthDay)—Apps for managing diabetes and calculating the risk of cardiovascular disease are among the top 10 apps doctors recommend to their patients, according to researchers at Medical Economics.
Aug 31, 2013
0
0
(HealthDay)—The top five concerns of medical practice executives all relate to financial management, with dealing with increasing operating costs reported as the most difficult daily challenge, according to a report published ...
Aug 20, 2013
0
0
Fewer Americans may be feeling the blues, with rates of depression in people over 50 on the decline, according to a new University of Michigan Health System study.
Jul 10, 2013
0
0
The term "Type 2 diabetes" is leading medical researchers astray, and resulting in sub-optimal treatment for patients, says a leading diabetes expert in a Viewpoint published in the Lancet.
May 30, 2013
0
0
